Clearpoint Neuro Inc (CLPT)
Healthcare
Medical Devices
14.90 $
+2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Clearpoint Neuro Inc (CLPT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.6% of the shares are freely tradable; institutional investors hold 50.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
50.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
8.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
87.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
17.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
30Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.94 | 2,082,750 | +1.9 | 03/31/2026 |
| Mak Capital One LLC | 6.34 | 1,901,489 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 5.89 | 1,766,677 | +18.0 | 12/31/2025 |
| Vanguard Capital Management, LLC | 4.15 | 1,243,615 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.35 | 705,720 | +7.9 | 03/31/2026 |
| State Street Corp | 2.27 | 679,819 | +8.2 | 03/31/2026 |
| Lane Generational LLC | 1.62 | 486,849 | +42.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.96 | 887,504 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.20 | 660,464 | +0.9 | 05/29/2026 |
| Rolnik Focus FIL | 1.67 | 500,000 | +0.0 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.